Your browser doesn't support javascript.
Risk Factors for Illness Severity Among Pregnant Women With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Infection-Surveillance for Emerging Threats to Mothers and Babies Network, 22 State, Local, and Territorial Health Departments, 29 March 2020-5 March 2021.
Galang, Romeo R; Newton, Suzanne M; Woodworth, Kate R; Griffin, Isabel; Oduyebo, Titilope; Sancken, Christina L; Olsen, Emily O'Malley; Aveni, Kathryn; Wingate, Heather; Shephard, Hanna; Fussman, Chris; Alaali, Zahra S; Silcox, Kristin; Siebman, Samantha; Halai, Umme-Aiman; Lopez, Camille Delgado; Lush, Mamie; Sokale, Ayomide; Barton, Jerusha; Chaudhary, Ifrah; Patrick, Paul H; Schlosser, Levi; Reynolds, Bethany; Gaarenstroom, Nicole; Chicchelly, Sarah; Read, Jennifer S; de Wilde, Leah; Mbotha, Deborah; Azziz-Baumgartner, Eduardo; Hall, Aron J; Tong, Van T; Ellington, Sascha; Gilboa, Suzanne M.
  • Galang RR; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Newton SM; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Woodworth KR; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Griffin I; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Oduyebo T; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Sancken CL; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Olsen EO; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Aveni K; Division of Family Health Services, New Jersey Department of Health, Trenton, New Jersey, USA.
  • Wingate H; Communicable and Environmental Disease and Emergency Preparedness, Tennessee Department of Health, Nashville, Tennessee, USA.
  • Shephard H; Bureau of Family Health and Nutrition, Massachusetts Department of Public Health, Boston, Massachusetts, USA.
  • Fussman C; Maternal and Child Health Epidemiology Section, Michigan Department of Health and Human Services, Lansing, Michigan, USA.
  • Alaali ZS; Division of Epidemiology, New York State Department of Health, Albany, New York, USA.
  • Silcox K; Maternal and Child Health Bureau, Maryland Department of Health, Baltimore, Maryland, USA.
  • Siebman S; Emerging Infections Program, Minnesota Department of Health, St Paul, Minnesota, USA.
  • Halai UA; Acute Communicable Disease Control Program, Los Angeles County Department of Public Health, Los Angeles, California, USA.
  • Lopez CD; Division of Children With Special Medical Needs, Puerto Rico Department of Health, San Juan, Puerto Rico, USA.
  • Lush M; Division of Public Health, Nebraska Department of Health and Human Services, Lincoln, Nebraska, USA.
  • Sokale A; Division of Maternal, Child and Family Health, Philadelphia Department of Public Health, Philadelphia, Pennsylvania, USA.
  • Barton J; Epidemiology Division, Georgia Department of Public Health, Atlanta, Georgia, USA.
  • Chaudhary I; Division of Disease Prevention and Control, Houston Health Department, Houston, Texas, USA.
  • Patrick PH; Perinatal and Reproductive Health Division, Oklahoma State Department of Health, Oklahoma City, Oklahoma, USA.
  • Schlosser L; Division of Disease Control, North Dakota Department of Health, Bismarck, North Dakota, USA.
  • Reynolds B; Bureau of Epidemiology, Pennsylvania Department of Health, Pittsburgh, Pennsylvania, USA.
  • Gaarenstroom N; Nevada High Sierra Area Health Education Center, Reno, Nevada, USA.
  • Chicchelly S; Infectious Disease Epidemiology and Response, Kansas Department of Health and Environment, Topeka, Kansas, USA.
  • Read JS; Infectious Disease Epidemiology, Vermont Department of Health, Burlington, Vermont, USA.
  • de Wilde L; Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.
  • Mbotha D; Epidemiology Division, US Virgin Islands Department of Health, Christiansted, St Croix, US Virgin Islands.
  • Azziz-Baumgartner E; Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, Washington, USA.
  • Hall AJ; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Tong VT; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Ellington S; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Gilboa SM; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clin Infect Dis ; 73(Suppl 1): S17-S23, 2021 07 15.
Article in English | MEDLINE | ID: covidwho-1364779
ABSTRACT

BACKGROUND:

Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness compared with nonpregnant women. Data to assess risk factors for illness severity among pregnant women with COVID-19 are limited. This study aimed to determine risk factors associated with COVID-19 illness severity among pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

METHODS:

Pregnant women with SARS-CoV-2 infection confirmed by molecular testing were reported during 29 March 2020-5 March 2021 through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET). Criteria for illness severity (asymptomatic, mild, moderate-to-severe, or critical) were adapted from National Institutes of Health and World Health Organization criteria. Crude and adjusted risk ratios for moderate-to-severe or critical COVID-19 illness were calculated for selected demographic and clinical characteristics.

RESULTS:

Among 7950 pregnant women with SARS-CoV-2 infection, moderate-to-severe or critical COVID-19 illness was associated with age 25 years and older, healthcare occupation, prepregnancy obesity, chronic lung disease, chronic hypertension, and pregestational diabetes mellitus. Risk of moderate-to-severe or critical illness increased with the number of underlying medical or pregnancy-related conditions.

CONCLUSIONS:

Older age and having underlying medical conditions were associated with increased risk of moderate-to-severe or critical COVID-19 illness among pregnant women. This information might help pregnant women understand their risk for moderate-to-severe or critical COVID-19 illness and can inform targeted public health messaging.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / COVID-19 Type of study: Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Pregnancy Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / COVID-19 Type of study: Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Pregnancy Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid